We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CBA:ASXCommonwealth Bank of Australia Analysis

Data as of 2026-08-30 - not real-time

A$157.25

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Commonwealth Bank of Australia trades at AUD 157.25, with its moving averages tangled rather than clearly stacked — a neutral trend structure. The last 30 days have lost 8.5%. With RSI at 32.2 the momentum picture is approaching oversold, alongside a bearish MACD signal. Recent trading has carved out support near AUD 154.38 and resistance around AUD 181.40.
On valuation the read is overvalued — earnings multiple of 24.2 versus a 17.0 sector average, above the peer group. Analyst price targets sit 20.4% below the current price. Revenue is growing at 6.5% on a 37.0% profit margin. The 3.21% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 18.1%, a beta of 0.27 and a maximum drawdown of 17.6%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons line up on sell — conviction 5 out of 10.

Top Market Events

Commonwealth Bank of Australia's ASX:CBA fiscal 2026 results topped analyst estimates, helped by gAre Commonwealth Bank of Australia ASX: CBA shares a buy after the bank raked in $11 billion in profits?Australian shares are poised to fall on Wednesday, tracking a softer gold price as investors await k

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 5/10

Key Factors

  • Trading below the 200-day average of 165.59
  • MACD momentum is negative
  • 30-day price change of -8.5%

Medium Term

1–3 years
Cautious
Model confidence: 5/10

Key Factors

  • P/E of 24.2 versus sector average of 17.0
  • Trading below the 200-day average of 165.59
  • Analyst targets imply -20.4% versus the current price

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • P/E of 24.2 versus sector average of 17.0
  • Analyst targets imply -20.4% versus the current price
  • Profit margin of 37.0% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth6.50%
Profit Margin37.00%
P/E Ratio24.2
ROE13.86%
ROA0.78%
P/B Ratio3.3
Op. Cash FlowA$-86123003904
Industry P/E17.0

Technical Analysis

TrendNeutral
RSI32.2
SupportA$154.38
ResistanceA$181.40
MA 20A$166.81
MA 50A$168.16
MA 200A$165.59
MACDBearish
VolumeIncreasing
Fear & Greed Index95.66

Valuation

Target PriceA$125.21
Upside/Downside-20.37%
GradeOvervalued
TypeBlend
Dividend Yield3.21%

Risk Assessment

Beta0.27
Volatility18.10%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.